One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease.
Daniel Y LuMatthew D SayboltDaniel H KissWilliam H MatthaiKimberly A FordeJay GiriRobert L WilenskyPublished in: Clinical Medicine Insights. Cardiology (2020)
Percutaneous coronary intervention in patients with cirrhosis is associated with an elevated risk of adverse events, including severe bleeding and AKI.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery disease
- atrial fibrillation
- coronary artery bypass grafting
- acute kidney injury
- coronary artery bypass
- early onset
- type diabetes
- heart failure
- metabolic syndrome
- glycemic control
- insulin resistance